Co-Diagnostics Files Initial Annual Report on Form 10-K and Updates Corporate Developments
CODX updates on initial six months as a public company SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics ...
Home » DNA
CODX updates on initial six months as a public company SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics ...
Project moving forward on schedule, with production to begin in Q3 2018 SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX), a ...
SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform ...
Audit to prepare for eventual sales into the US market SALT LAKE CITY--CODX, (BUSINESS WIRE)-- Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or ...